Grannum R. Sant
Director/Board Member chez Cellanyx Diagnostics LLC
Profil
Grannum R.
Sant is currently a Director at Cellanyx Diagnostics LLC and Xennials Therapeutics, Inc. He previously served as an Independent Director at Photocure ASA. He was also a Vice President & Head of Medical Affairs at Sanofi, Inc. from 2003 to 2013 and a VP & Head-Global Medical Affairs Rare at Genzyme Corp.
from 2010 to 2013.
He has also worked as a Professor at Tufts University School of Medicine.
Dr. Sant holds a doctorate degree from University College Dublin.
Postes actifs de Grannum R. Sant
| Sociétés | Poste | Début |
|---|---|---|
Cellanyx Diagnostics LLC
 Cellanyx Diagnostics LLC Medical SpecialtiesHealth Technology Cellanyx Diagnostics LLC is a company that is developing a cancer testing platform to aid clinical decision-making. The company is based in Beverly, MA and was founded by Ashok Chander and Michael Manak. The company's technology provides quantitative assessments of individual cancer cells in biopsy samples using multiple biochemical and biophysical markers of tumor aggressiveness and metastatic potential. The company has demonstrated clinical proof-of-concept with their lead test in development, which aims to improve risk stratification in men with prostate cancer. | Director/Board Member | - |
Xennials Therapeutics, Inc.
 Xennials Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xennials Therapeutics, Inc. develops and manufactures transformative therapies. | Director/Board Member | - |
Anciens postes connus de Grannum R. Sant
| Sociétés | Poste | Fin |
|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2013 |
Sanofi, Inc.
 Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a private company based in New York, NY. | Corporate Officer/Principal | 01/01/2013 |
| Tufts University School of Medicine | Corporate Officer/Principal | - |
| PHOTOCURE ASA | Director/Board Member | - |
Formation de Grannum R. Sant
| University College Dublin | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PHOTOCURE ASA | Health Technology |
| Entreprise privées | 4 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Sanofi, Inc.
Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a private company based in New York, NY. | Retail Trade |
Cellanyx Diagnostics LLC
Cellanyx Diagnostics LLC Medical SpecialtiesHealth Technology Cellanyx Diagnostics LLC is a company that is developing a cancer testing platform to aid clinical decision-making. The company is based in Beverly, MA and was founded by Ashok Chander and Michael Manak. The company's technology provides quantitative assessments of individual cancer cells in biopsy samples using multiple biochemical and biophysical markers of tumor aggressiveness and metastatic potential. The company has demonstrated clinical proof-of-concept with their lead test in development, which aims to improve risk stratification in men with prostate cancer. | Health Technology |
Xennials Therapeutics, Inc.
Xennials Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xennials Therapeutics, Inc. develops and manufactures transformative therapies. | Health Technology |
